NCT00951301View on ClinicalTrials.gov

Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation

PHASE1TerminatedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Atrial Fibrillation
Interventions
DRUG

mangosteen juice

6 ounces of juice containing mangosteen taken twice daily, AM and PM, for 6 months duration of study participation.

DRUG

placebo juice

6 ounces of specially prepared juice not containing mangosteen taken twice daily, AM and PM, for 6 months duration of the study participation.

Trial Locations (1)

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER